Methotrexate – not an antibiotic
Methotrexate (MTX) is often confused with antibiotics because it is a medication that “hits” bacterial‑like pathways in the body. In reality, it is a folate analog that blocks DNA synthesis in rapidly dividing cells. It is used mainly for:
| Indication | Typical use |
|------------|-------------|
| Cancer (leukemias, lymphomas, osteosarcoma, etc.) | Chemotherapy – high‑dose MTX |
| Autoimmune diseases | Rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis |
| Other conditions | Systemic lupus erythematosus, ectopic pregnancy (abortive therapy), severe psoriasis, Crohn’s disease (rare), etc. |
How it works
- Folate inhibition – MTX competitively inhibits dihydrofolate reductase (DHFR), preventing the conversion of dihydrofolate to tetrahydrofolate.
- DNA synthesis blockade – Without tetrahydrofolate, the cell can’t produce thymidylate and purines, essential for DNA replication and repair.
- Anti‑inflammatory effect – In immune‑mediated diseases it reduces proliferation of activated T cells and production of inflammatory cytokines.
Key points
| Topic | Details |
|-------|---------|
| Not an antibiotic | MTX does not target bacteria. It targets human cells. |
| Common side effects | Nausea, mouth ulcers, fatigue, myelosuppression (low blood counts), hepatotoxicity, pneumonitis, kidney toxicity. |
| Monitoring | CBC, liver enzymes, renal function, urinalysis, pregnancy test (it is teratogenic). |
| Drug interactions | NSAIDs, sulfonamides, proton‑pump inhibitors, allopurinol, certain antivirals, some antibiotics (e.g., fluoroquinolones can increase MTX levels). |
| Contraindications | Pregnancy, lactation, active infection, severe renal/hepatic impairment, uncontrolled heart disease, known hypersensitivity. |
| Dose | Depends on indication. For rheumatoid arthritis, typical oral dose is 7.5–25 mg weekly; for cancer, it can be 100–500 mg/m² IV with a multi‑day schedule. |
| Supplementation | Folic acid (folinic acid rescue) is routinely given to mitigate some side effects, especially in rheumatology. |
| Safety | Methotrexate is a Schedule X drug in many countries due to its teratogenicity. Women of childbearing potential must use reliable contraception. |
Quick FAQ
Q: Can methotrexate be used to treat infections?
A: No. It has no antibacterial activity and would actually suppress the immune response needed to fight infections.
Q: Is it safe for pregnant patients?
A: Absolutely not. MTX is a known teratogen and contraindicated in pregnancy. A strict pregnancy‑testing protocol is required before starting therapy.
Q: How does it compare to antibiotics?
A: Antibiotics inhibit or kill bacteria (e.g., penicillins, macrolides). MTX inhibits cell division in human cells, which can affect both malignant and immune cells.
Q: What are the most serious adverse events?
A: Myelosuppression leading to severe neutropenia or anemia, hepatotoxicity (elevated ALT/AST), pulmonary toxicity, and kidney damage. These are why regular lab monitoring is essential.
---
Bottom line: Methotrexate is a powerful anti‑proliferative drug used mainly for cancer and autoimmune disorders. It is not an antibiotic and should not be used for bacterial infections. If you or someone you know has been prescribed MTX, follow the prescribing clinician’s monitoring plan carefully, and keep a close eye on labs and any signs of toxicity. If you have specific questions about dosing, side‑effect management, or drug interactions, let me know!